Habach
Germany
116
2026-03-26
The entities that hold a legal rights for patent applications filed by inventor Georges Guy:
Guy Georges from Habach, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
ALL-IN-ONE AGONISTIC ANTIBODIES
#2 | 2026-03-05ANTIGEN BINDING MOLECULES
#3 | 2025-12-11HUMANIZED ANTI-HUMAN CD19 ANTIBODIES AND METHODS OF USE
#4 | 2025-11-27METHOD FOR GENERATING MULTISPECIFIC ANTIBODIES FROM MONOSPECIFIC ANTIBODIES
#5 | 2025-11-27METHOD FOR GENERATING MULTISPECIFIC ANTIBODIES FROM MONOSPECIFIC ANTIBODIES
#6 | 2025-08-21Method for discovery of alternative antigen specific antibody variants
#7 | 2025-06-05NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP
#8 | 2025-05-15ANTI-TRANSFERRIN RECEPTOR ANTIBODIES WITH TAILORED AFFINITY
#9 | 2025-02-13ANTI-A-BETA PROTEIN ANTIBODIES, METHODS AND USES THEREOF
#10 | 2025-01-30AGONISTIC LTBR ANTIBODIES AND BISPECIFIC ANTIBODIES COMPRISING THEM
#11 | 2024-11-07AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM
#12 | 2024-10-31BISPECIFIC ANTI-CCL2 ANTIBODIES
#13 | 2024-09-05ANTI-PD1 ANTIBODIES AND METHODS OF USE
#14 | 2024-08-15ANTI-TIM3 ANTIBODIES AND METHODS OF USE
#15 | 2024-08-08PRECURSOR PROTEINS AND KIT FOR TARGETED THERAPY
#16 | 2024-05-23CONTORSBODY - A SINGLE CHAIN TARGET BINDER
#17 | 2024-02-29Antibodies binding to NKG2D
#18 | 2024-02-08ANTI-BRDU ANTIBODIES AND METHODS OF USE
#19 | 2023-12-14BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
#20 | 2023-09-07ANTI-TIM3 ANTIBODIES AND METHODS OF USE
#21 | 2023-08-24Humanized anti-Tau(PS422) antibodies and methods of use
#22 | 2023-07-13Anti-transferrin receptor antibodies with tailored affinity
#23 | 2023-06-15ANTI-PD1 ANTIBODIES AND METHODS OF USE
#24 | 2023-05-11ANTI-PD1 ANTIBODIES AND METHODS OF USE
#25 | 2022-11-17ANTI-TIM3 ANTIBODIES AND METHODS OF USE
#26 | 2022-06-30Humanized anti-human CD19 antibodies and methods of use
#27 | 2022-03-31METHOD FOR GENERATING AVID-BINDING MULTISPECIFIC ANTIBODIES
#28 | 2022-02-10THERAPEUTIC MULTISPECIFIC POLYPEPTIDES ACTIVATED BY POLYPEPTIDE CHAIN EXCHANGE
#29 | 2022-02-03GENERATION OF ANTIBODY-DERIVED POLYPEPTIDES BY POLYPEPTIDE CHAIN EXCHANGE
#30 | 2021-11-11CONTORSBODY - A SINGLE CHAIN TARGET BINDER
#31 | 2021-05-13Humanized anti-Tau(pS422) antibodies and methods of use
#32 | 2021-03-11Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
#33 | 2021-02-18BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
#34 | 2021-02-04Antibodies binding to NKG2D
#35 | 2021-01-28MODIFIED PSEUDOMONAS EXOTOXIN A
#36 | 2020-12-03VH-VL INTERDOMAIN ANGLE BASED ANTIBODY HUMANIZATION
#37 | 2020-09-17Bispecific HER2 antibodies and methods of use
#38 | 2020-07-16Three-dimensional structure-based humanization method
#39 | 2020-07-16HUMANIZED ANTI-TAU(PS422) ANTIBODIES AND METHODS OF USE
#40 | 2020-07-09Method for discovery of alternative antigen specific antibody variants
#41 | 2020-06-11MODIFIED PSEUDOMONAS EXOTOXIN A
#42 | 2020-05-28Covalently linked antigen-antibody conjugates
#43 | 2020-02-20Anti-transferrin receptor antibodies with tailored affinity
#44 | 2020-01-02Anti-BRDU antibodies and methods of use
#45 | 2020-01-02Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
#46 | 2019-12-26THE CONTORSBODY - A SINGLE CHAIN TARGET BINDER
#47 | 2019-12-19ANTI-PD1 ANTIBODIES AND METHODS OF USE
#48 | 2019-12-19ANTI-TIM3 ANTIBODIES AND METHODS OF USE
#49 | 2019-10-03ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF
#50 | 2019-03-07Antibodies against human CSF-1R and uses thereof
#51 | 2019-02-28Antibodies specific for DR5 and methods of use
#52 | 2018-11-29NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP
#53 | 2018-10-04Humanized anti-human CD19 antibodies and methods of use
#54 | 2018-10-04Anti-transferrin receptor antibodies with tailored affinity
#55 | 2018-07-26Antibodies against human CSF-1R and uses thereof
#56 | 2018-05-03Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4
#57 | 2018-04-05HER3 antigen binding proteins binding to the beta-hairpin of HER3
#58 | 2018-03-22Humanized anti-tau(pS422) antibodies and methods of use
#59 | 2018-03-15ANTI-TIM3 ANTIBODIES AND METHODS OF USE
#60 | 2017-12-28BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
#61 | 2017-08-31ANTI-PD1 ANTIBODIES AND METHODS OF USE
#62 | 2017-08-31Anti-IL-1beta antibodies
#63 | 2017-08-31Anti-ANG2 antibodies and methods of use
#64 | 2017-08-31Anti-PDGF-B antibodies and methods of use
#65 | 2017-08-24Bispecific antibodies and methods of use in ophthalmology
#66 | 2017-07-20VH-VL-INTERDOMAIN ANGLE BASED ANTIBODY HUMANIZATION
#67 | 2017-06-22Anti-HER3 antibodies and uses thereof
#68 | 2017-05-11Humanized anti-Tau(pS422) antibodies and methods of use
#69 | 2017-04-27ANTI-BRDU ANTIBODIES AND METHODS OF USE
#70 | 2017-03-02Covalently linked helicar-anti-helicar antibody conjugates and uses thereof
#71 | 2017-02-23MODIFIED PSEUDOMONAS EXOTOXIN A
#72 | 2017-02-02Bispecific HER2 antibodies and methods of use
#73 | 2017-01-12Use of the binding domain of a subunit of a multi-subunit structure for targeted delivery of pharmaceutically active entities to the multi-subunit structure
#74 | 2016-12-29Humanized anti-tau(pS422) antibodies and methods of use
#75 | 2016-11-10Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
#76 | 2016-09-08ANTI-TIM3 ANTIBODIES AND METHODS OF USE
#77 | 2016-01-14Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
#78 | 2015-12-03Disulfide-linked multivalent MHC class I comprising multi-function proteins
#79 | 2015-09-17Covalently linked antigen-antibody conjugates
#80 | 2015-08-27Anti-theophylline antibodies and methods of use
#81 | 2015-08-20Anti-biotin antibodies and methods of use
#82 | 2015-06-25Humanized anti-Tau(pS422) antibodies and methods of use
#83 | 2015-04-09Modified exotoxin A
#84 | 2015-01-01Bispecific anti-VEGF/anti-ANG-2 antibodies
#85 | 2014-12-25Anti-HER3 antibodies and uses thereof
#86 | 2014-12-25ANTI-HER3 ANTIBODIES AND USES THEREOF
#87 | 2014-12-18Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5
#88 | 2014-10-09Antibodies against human IL33R and uses thereof
#89 | 2014-07-03HER3 antibodies binding to the beta-hairpin of HER3
#90 | 2014-07-03Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4
#91 | 2013-08-15Humanized anti-CDCP1 antibodies
#92 | 2013-08-01ANTIBODIES AGAINST HUMAN IL17 AND USES THEREOF
#93 | 2013-03-28Anti-MCSP antibodies
#94 | 2012-12-20Bispecific anti-VEGF/anti-ANG-2 antibodies
#95 | 2012-11-08Bi-specific digoxigenin binding antibodies
#96 | 2012-10-25Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
#97 | 2012-08-23Antibodies against human IL33R and uses thereof
#98 | 2012-01-26Antibodies specifically binding to human TSLPR and methods of use
#99 | 2011-09-08PYRIDONEAMIDE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS
#100 | 2011-07-14Anti-HER3 antibodies and uses thereof
165126 ⎘